Arteriovenous malformations (AVMs) of the basal ganglia (BG) and thalamus are associated with elevated risks of both hemorrhage if left untreated and neurological morbidity after resection. Therefore, stereotactic radiosurgery (SRS) has become a mainstay in the management of these lesions, although its safety and efficacy remain incompletely understood. The aim of this retrospective multicenter cohort study was to evaluate the outcomes of SRS for BG and thalamic AVMs and determine predictors of successful endpoints and adverse radiation effects.
The authors retrospectively reviewed data on patients with BG or thalamic AVMs who had undergone SRS at eight institutions participating in the International Gamma Knife Research Foundation (IGKRF) from 1987 to 2014. Favorable outcome was defined as AVM obliteration, no post-SRS hemorrhage, and no permanently symptomatic radiation-induced changes (RICs). Multivariable models were developed to identify independent predictors of outcome.
The study cohort comprised 363 patients with BG or thalamic AVMs. The mean AVM volume and SRS margin dose were 3.8 cm3 and 20.7 Gy, respectively. The mean follow-up duration was 86.5 months. Favorable outcome was achieved in 58.5% of patients, including obliteration in 64.8%, with rates of post-SRS hemorrhage and permanent RIC in 11.3% and 5.6% of patients, respectively. Independent predictors of favorable outcome were no prior AVM embolization (p = 0.011), a higher margin dose (p = 0.008), and fewer isocenters (p = 0.044).
SRS is the preferred intervention for the majority of BG and thalamic AVMs. Patients with morphologically compact AVMs that have not been previously embolized are more likely to have a favorable outcome, which may be related to the use of a higher margin dose.
ABBREVIATIONSAVM = arteriovenous malformation; BG = basal ganglia; DSA = digital subtraction angiography; EBRT = external beam radiation therapy; IGKRF = International Gamma Knife Research Foundation; mRBAS = modified radiosurgery-based AVM score; RIC = radiation-induced change; SM = Spetzler-Martin; SRS = stereotactic radiosurgery; VRAS = Virginia Radiosurgery AVM Scale.
Correspondence Ching-Jen Chen: University of Virginia Health System, Charlottesville, VA. firstname.lastname@example.org.
INCLUDE WHEN CITING Published online January 11, 2019; DOI: 10.3171/2018.8.JNS182106.
Disclosures Dr. Grills reports stock ownership and serving on the board of directors for the Greater Michigan Gamma Knife, and she reports receiving through her institution research funding from Elekta, which is unrelated to this study. Dr. Lunsford reports stock ownership in Elekta AB and serving on the data safety monitoring board for Insightec.
DingDLiuKC: Predictive capability of the Spetzler-Martin versus Supplementary Grading Scale for microsurgical outcomes of cerebellar arteriovenous malformations. J Cerebrovasc Endovasc Neurosurg15:307–3102013
DingDStarkeRMKanoHMathieuDHuangPKondziolkaD: Radiosurgery for cerebral arteriovenous malformations in A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA)–eligible patients: a multicenter study. Stroke47:342–3492016
HongCSPetersonECDingDSurSHasanDDumontAS: Intervention for a randomized trial of unruptured brain arteriovenous malformations (ARUBA)–eligible patients: an evidence-based review. Clin Neurol Neurosurg150:133–1382016
KanoHKondziolkaDFlickingerJCYangHCFlanneryTJNiranjanA: Stereotactic radiosurgery for arteriovenous malformations, Part 4: management of basal ganglia and thalamus arteriovenous malformations. J Neurosurg116:33–432012
LeeCCReardonMABallBZChenCJYenCPXuZ: The predictive value of magnetic resonance imaging in evaluating intracranial arteriovenous malformation obliteration after stereotactic radiosurgery. J Neurosurg123:136–1442015
MohrJPParidesMKStapfCMoqueteEMoyCSOverbeyJR: Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet383:614–6212014
PollockBEKondziolkaDFlickingerJCPatelAKBissonetteDJLunsfordLD: Magnetic resonance imaging: an accurate method to evaluate arteriovenous malformations after stereotactic radiosurgery. J Neurosurg85:1044–10491996
RussellDPeckTDingDChenCJTaylorDGStarkeRM: Stereotactic radiosurgery alone or combined with embolization for brain arteriovenous malformations: a systematic review and meta-analysis. J Neurosurg128:1338–13482018
ValleRDZentenoMJaramilloJLeeADe AndaS: Definition of the key target volume in radiosurgical management of arteriovenous malformations: a new dynamic concept based on angiographic circulation time. J Neurosurg109Suppl:41–502008
WegnerREOysulKPollockBESirinSKondziolkaDNiranjanA: A modified radiosurgery-based arteriovenous malformation grading scale and its correlation with outcomes. Int J Radiat Oncol Biol Phys79:1147–11502011